Defining the contribution of genetic risk to structural and functional anomalies in ADHD

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 47, Issue 1, 2008, Pages 2-3

  Rapoport, Judith L ^a   Shaw, Philip ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER;

ATTENTION DEFICIT DISORDER; BRAIN SIZE; CEREBELLUM; COGNITION; CORPUS STRIATUM; EDITORIAL; FUNCTIONAL DISEASE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; METABOLIC DISORDER; NEUROPATHOLOGY; PHENOTYPE; PRIORITY JOURNAL;

EID: 37849007193     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/chi.0b013e31815aac83     Document Type: Editorial

References (12)

1. Durston S, Fossella JA, Mulder MJ, et al. Dopamine-transporter genotype conveys familial risk for attention-deficit/hyperactivity disorder through striatal activation. J Am Acad Child Adolesc Psychiatry. 2008;47:62-68.
2. Mulder MJ, Baeyens D, Davidson MC, et al. Familial vulnerability for ADHD affects activity in cerebellum in addition to prefrontal systems. J Am Acad Child Adolesc Psychiatry. 2008;47:69-76.
3. Zametkin AJ, Nordahl TE, Gross M, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med. 1990;323:1361-1366.
4. Castellanos FX, Lee PP, Sharp W, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/ hyperactivity disorder. JAMA. 2002;288:1740-1748.
5. Faraone SV, Khan SA. Candidate gene studies of attention-deficit/ hyperactivity disorder. J Clin Psychiatry. 2006;67(Suppl 8):13-20.
6. Durston S. A review of the biological bases of ADHD: what have we learned from imaging studies? Ment Retard Dev Disabil Res Rev. 2003;9:184-195.
7. Durston S, Hulshoff Pol HE, Schnack HG, et al. Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. J Am Acad Child Adolesc Psychiatry. 2004;43:332-340.
8. Mill J, Caspi A, Williams BS, et al. Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: evidence from 2 birth cohorts. Arch Gen Psychiatry. 2006;63:462-469.
9. Bellgrove MA, Hawi Z, Kirley A, et al. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder. Neuropsychopharmacology. 2005;30:2290-2297.
10. Vaidya CJ, Austin G, Kirkorian G, et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci U S A. 1998;95:14494-14499.
11. Desmond JE. Neuroimaging studies of the cerebellum: language, learning, and memory. Trends Cogn Sci. 1998;2:355-362.
12. Mackie S, Shaw P, Lenroot R, et al. Cerebellar development and clinical outcome in attention deficit hyperactivity disorder. Am J Psychiatry. 2007;164:647-655.